Skip to main content
Erschienen in: International Ophthalmology 10/2023

Open Access 03.07.2023 | Original Paper

Aldose reductase and glutathione in senile cataract nucleus of diabetics and non-diabetics

verfasst von: Kanishk Khare, Teena Mendonca, Gladys Rodrigues, Manjunath Kamath, Anupama Hegde, Shyamala Nayak, Ajay Kamath, Sumana Kamath

Erschienen in: International Ophthalmology | Ausgabe 10/2023

Abstract

Purpose

The aim is to evaluate the aldose reductase (AR) and glutathione (GSH) activity in the nucleus of senile cataract in type 2 diabetes and non-diabetic group of patients.

Methods

A total of 62 patients including 31 diabetics and 31 non- diabetics who were undergoing cataract surgery were included. Nucleus extracted was sent for analysis of AR and GSH activity while blood sample was taken for glycated haemoglobin (HbA1c) levels.

Statistical analysis

Data were analysed using IBM SPSS 25. Comparison was carried out by unpaired T-test and correlations were established by Pearson’s correlation. The p value less than 0.05 was considered significant for all analyses.

Study design

This is a prospective cross-sectional comparative study.

Results

In this study, diabetic group patients showed earlier progression of cataract as compared to the non-diabetic group (p-value 0.0310). Mean HbA1c in the diabetic group was 7.34% compared to the non-diabetic group of 5.7% (p value < 0.001). AR in the diabetic patients was 2.07 mU/mg while the non-diabetic group was 0.22 mU/mg (p-value < 0.001). GSH in the diabetic group was 3.38 μMol/g and the non-diabetic group was 7.47 μMol/g (p value < 0.001). HbA1c showed positive correlation with AR among the diabetic group (p-value 0.028).

Conclusion

Elevated oxidative stress can be strongly attributed to high AR and low GSH activity among the diabetic group as compared to the non-diabetic group and can lead to early cataract formation.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Cataract is the foremost cause of preventable visual impairment globally, contributing approximately 94 million cases [1]. Considering the socio-economic parameters, the prevalence among the low- and middle-income groups and regions contributes four times higher number of cases in the visual impairment than the higher-income groups and region [1]. With the global increase in lifespan and ageing population, cataract contributes to approximately 15 million cases above the age of 50 years causing blindness. Among the moderate to severe visual impairment (MSVI) group, cataract contributes to 78.8 million cases [1].
Aetiopathogenesis of acquired cataract is multifactorial. Numerous studies have contributed towards the genetic, nutritional, biochemical, epidemiological and photochemical aspects of development of cataract. Various studies have been carried out categorize the etiological factors on the basis of different morphological development of cataract, namely cortical, nuclear sclerosis and subcapsular type [2].
Major pathogenesis contributing to senile cataract includes breakdown and protein aggregation, damage to fibre cell membranes, glutathione deficiency, damage by oxidative stress, calcium levels elevation and abnormal migration of lens epithelial cell [3]. The risk factors that may trigger or accelerate such events includes UV radiations, smoking, diabetes, dehydration crisis, oxidative stress, hyperlipidaemia, etc. [4] to name a few.
One of the key biochemical factor maintaining the oxidative balance in the lens is the reducing agent glutathione (GSH). In various studies it has found that GSH is one of the most vital anti-oxidant factor of the lens [5]. The synthesis and recycling of glutathione falls with age [6].
Patients with diabetes mellitus have been found at risk of early cataract development up to five times as compared to non-diabetics [6]. Various studies have been carried out in the past highlighting the role of sorbitol or polyol pathway in cataract formation and progression among the diabetic patients [7]. In the patients with poor glycaemic control, polyol pathway is activated to process the glucose. Aldose reductase (AR) is the crucial enzyme in this process. Sorbitol and fructose accumulation in the lens epithelium and lens fibres is reflected as osmotic trauma, leading to lens opacification [7].
Previous studies have measured the value of glutathione and aldose reductase in the blood of patients and correlated the levels in the diabetic population and non- diabetic population [8]. Few studies on animal models have been conducted to determine the levels of these enzymes in the nucleus also [9]. This study emphasizes the oxidative stress in the nucleus of senile cataract among the two group of patients by measuring and comparing these two biochemical parameters in the lens and correlating their values with the glycaemic control.

Materials and methods

Study setting

Kasturba Medical College, Government Wenlock Hospital, Mangalore and Department of Biochemistry.

Study design

Prospective cross-sectional comparative study.

Study participants

Patients undergoing small incision cataract surgery.

Inclusion criteria for cases

All senile cataract patients undergoing cataract surgery who are a known case of type-2 diabetes and on medication.

Inclusion criteria for controls

All senile cataract patients undergoing cataract surgery who are not a known case of type-2 diabetes.

Exclusion criteria for cases and controls:

1)
Cataract in age less than 50 years.
 
2)
Type-1 diabetics.
 
3)
Complicated, traumatic and congenital cataracts.
 

Study period

October, 2019–September, 2021.

Sample size

With 95% confidence level and 90% power with respect to reference article, sample size is 62 cases: 31 patients in diabetic group and 31 patients in the non- diabetic group with cataract.
$$N = 2\;(Z_{\alpha } \times Z_{\beta } )2 \times \delta_{2} /d_{2}$$
 = 1.96 at 95% confidence level.
 = 1.28 at 90% power.δ = 792.76, d = 650 (w.r.t. Reference article [8])

Sampling method

Non-random convenience sampling.

Data analysis

It was carried out by descriptive statistics. All the data were tabulated in excel sheet, followed by analyzing using IBM SPSS 25. Descriptive and categorical data have been represented as means ± std deviation and percentages, respectively. The T-test was used to compare mean age, RBS, HbA1c, AR, and GSH among the diabetic group of patients and non-diabetic group of patients, whereas, the variables gender, and cataract types between the two groups were compared using Chi-square analysis. Additionally, within the diabetic group, the mean HbA1c, AR, and GSH values across the diabetic retinopathy groups were also compared using T-test. The correlations were evaluated by Pearson’s correlation between the age, duration of diabetes, and HbA1c each with AR and GSH levels. Statistical significance was based on the p value, with less than 0.05 considered significant for all analyses.

Data collection tool

  • This study was conducted on patients with the senile cataract undergoing cataract surgery.
  • An informed consent was taken.
  • Detailed history, including the duration of diabetes and medication history, was taken followed by ophthalmic examination including visual assessment, anterior segment evaluation, dilated fundus examination using indirect ophthalmoscope.
  • Nucleus extracted during cataract surgery will be divided into two parts and transferred into two buffers, namely Na + K + biphosphate buffer and normal saline, to estimate the activity of aldose reductase and glutathione, respectively.
  • The nucleus was homogenized in a 1 ml volume of the same buffer. Homogenates were centrifuged at 27,000 × g for 20 min at 4 °C, and the supernatant was assayed for AR. AR was assayed by the method of Hayman et al. [10]
  • To determine lens GSH, 0.2 mL of the homogenized lens sample was added directly into tubes containing 0.2 mL of 1 mol/L perchloric acid supplemented with 2 mmol/L of disodium EDTA, vortex-mixed, and centrifuged for 5 min at 10,000 g (4 °C) to remove the protein precipitate. Lens GSH was determined in a clear supernatant using Ellman’s reagent [7]. 0.2 mL of this supernatant, 0.8 mL of 0.3 mmol/L Na2HPO4, and 0.2 mL of 5,5_ -dithiobis-2nitrobenzoic acid in 1% sodium citrate were added in succession. The intensity of the resulting yellow colour was read spectrophotometrically at 410 nm. [11]
  • Blood sample was collected for HbA1c, and values were noted.
The study was approved by the Institutional Ethics Committee of Kasturba Medical College, Mangalore. (IEC KMC MLR 10-19/473).

Results

Patient demographics

In our study total 62 patients were included, comprising 31 diabetics and 31 non-diabetics. The diabetic group patients mean age was 60.29 years (standard deviation of 6.59 years), while non-diabetic group was 64.87 years (standard deviation of 9.45 years) with p-value of 0.031, which is clinically significant.
The gender distribution in both the groups showed marginally a greater number of females. Diabetic group included 16 females and15 males, while the non- diabetic group comprised of 17 females and 14 males (p value 0.79).

Clinical and blood parameters

The distribution of type of cataract in diabetic group depicted maximum number of cases showing mixed type (45.2%), that is, with both nuclear sclerosis and posterior subcapsular opacification. Non-diabetic group had comparable number cases in each type of morphological distribution. The mean DM duration was 4.3 ± 3.06 years among 31 diabetics (p-value 1). On treatment front, 28(90.3%) among them were on orally administered anti-hyperglycaemic medication while only 3(9.7%) were on insulin formulation (Table 1).
Table 1
Comparison of distribution of cataract types using chi-square analysis
Group
n
Nuclear sclerosis
Posterior subcapsular + nuclear sclerosis
Senile mature cataract
Chi square (p value)
Diabetic
Count
6
14
11
1.66 (0.43)
 
%
19.4%
45.2%
35.5%
 
Non- diabetic
Count
10
10
11
 
 
%
32.3%
32.3%
35.5%
 
The mean HbA1c value in the diabetic group was 7.34% compared to the non- diabetic group of 5.7% with p value < 0.001 which was extremely significant (Table 2).
Table 2
Mean HbA1c and RBS value among the diabetics and non-diabetics
Variable
Group
N
Mean
Std. deviation
T statistic
p value
HbA1c (%)
Diabetic
31
7.339
1.3856
5.767
< 0.001
 
Non-diabetic
31
5.700
0.7638
  
RBS (mg/dL)
Diabetic
31
151.26
43.347
5.441
< 0.001
 
Non-diabetic
31
101.58
26.564
  
The mean random blood sugar (RBS) value in the diabetic group was 151 mg/dl compared to the non-diabetic group of 101 mg/dl with p-value < 0.001 which was extremely significant.

Biochemical parameters

Mean aldose reductase (AR) in the diabetic patients was 2.07 mU/mg of protein while the non-diabetic group was 0.22 mU/mg of protein with p-value less than 0.001. Mean glutathione activity in the diabetic group was 3.38 μMol/g of lens and the non-diabetic group was 7.47 μMol/g of lens (p value < 0.001) (Table 3).
Table 3
Mean AR and GSH activity
Variable
Group
N
Mean
Std. deviation
T statistic
p value
AR (mU/mg protein)
Diabetic
31
2.0713
1.53634
6.693
0.001
 
Non-diabetic
31
0.2161
0.14495
  
GSH (μMol/g lens)
Diabetic
31
3.3761
1.02500
− 16.377
0.001
 
Non-diabetic
31
7.4748
0.94399
  

Correlations

HbA1c values were correlated with the AR and GSH activity. HbA1c had a positive correlation with AR among the diabetic group with p-value of 0.028 (Table 4 and Fig. 1).
Table 4
Correlation of HBA1C with AR and GSH levels using Pearson’s correlation
Variables compared
Correlation
Diabetics
Non-diabetics
HbA1c versus AR
Correlation coefficient
0.394
− 0.126
 
p value
0.028
0.501
HbA1c versus GSH
Correlation coefficient
− 0.040
0.127
 
p value
0.831
0.497
Duration of type 2 diabetes mellites was correlated with the AR activity. Correlation coefficient was 0.44 which was significant with p value of 0.013. However, GSH activity had no significant correlation (Table 5 and Fig. 2).
Table 5
Correlation of duration of diabetes with AR and GSH levels in the diabetic group using Pearson’s correlation
Variables compared
Correlation
Diabetics
DM duration versus AR
Correlation coefficient
0.441
 
p value
0.013
DM duration versus GSH
Correlation coefficient
0.154
 
p value
0.408

Discussion

Various studies performed in the past have indicated rapid and frequent cataract progression in the presence of diabetes. Framingham Eye study reported higher prevalence of cataract up to three times in the diabetic patients aged below 65 years as compared to their non-diabetic counterparts [12]. Among people above 65 years of age cataract was more frequent among diabetics than non-diabetics [12]. Klein et al. [13] in their study found that diabetic patients showed earlier development of cataract than non-diabetic patients.
In the present study, the mean age of patients with cataracts was less in the diabetic group than the non-diabetic group and was statistically significant. Both the groups had marginally a greater number of female patients, 51.6% and 54.8%, respectively, as compared to the males in both the groups, 48.4% and 45.2%, respectively, though the values were not statistically significant (Table 2). Nevertheless, this is in accordance with the epidemiological data that states cataract is more widespread in women than men [14].
Morphologically, diabetes has been associated with cortical and subcapsular opacification of lens. In follow-up of a large cohort of the Beaver Dam Eye Study, they elicited the relationship between diabetes and cataract morphology. It showed an association between diabetes and incidence of posterior subcapsular cataract and cortical type of cataract [6]. In the present study, among the diabetic group maximum number (45.2%) of patients had mixed morphology of opacification including posterior subcapsular and nuclear sclerosis (Table 1). While the non-diabetic group showed comparable distribution of cataract on the basis of morphology (Table 1), values were not statistically significant. Nevertheless, this study showed similar trends as seen in the Blue Mountain Eye Study which reported increased incidence of posterior subcapsular type in diabetics [15].
The primary outcome of the present study is aldose reductase and glutathione activity in the crystalline lens nucleus. Polyol or sorbitol pathway has been extensively studied in the past for its role in cataract formation among the diabetic patients. However, this is the first study carried out to evaluate the aldose reductase (AR) and Glutathione (GSH) activity in the nucleus of senile cataract in type 2 diabetes and non-diabetic group of patients.
The first enzyme involved in this pathway is aldose reductase. It is the key initiator of sorbitol formation in the lens [16]. Sorbitol accumulation further increases the oxidative stress and causes opacification of lens fibres. Various animal models have been studied that have demonstrated the role of aldose reductase in cataract formation after inducing diabetes by either pancreatomy or chemical ablation of the beta cells responsible of insulin production in the pancreas [9]. Sorbitol accumulation also causes osmotic stress to the main centre of protein synthesis, endoplasmic reticulum (ER) [16, 17]. With fluctuation of glucose in the diabetics, ER also initiates unfolded protein response which causes reactive oxygen species (ROS) generation [7, 17]. These free radical scavengers will not only lead to damage to lens fibres, but also causes more consumption and henceforth reduction in GSH levels.
Bhatia et al. conducted a study among the senile cataract patients comparing the levels of aldose reductase in the blood of diabetics, non-diabetics and control group [8]. They found highest mean levels of AR in the diabetic group and was statistically significant [8]. In this study, the mean AR activity of lens nucleus among the diabetics was 2.07 mU/mg of protein as compared to 0.21 mU/mg of protein in the non-diabetic group. This was highly statistically significant with the p value of < 0.001 (Table 3). Apart from the AR activity, studies conducted on aldose reductase inhibitors (ARI) have also show regression of cataract in presence of diabetes in the animal models [18]. Hence, this again ascertains the role of AR in the cataract formation among the diabetic patients.
The cataract progression risk has been positively correlated in numerous studies with the duration of diabetes and poor glycaemic control among the diabetics [8, 19]. In the present study, the mean duration of diabetes was 4.3 years. Duration of diabetes had a significant positive correlation with the aldose reductase activity with value of 0.44 and p value of 0.03. This hence helps in eliciting the role of aldose reductase and the significance of duration of diabetes among the diabetic patients.
Studies have been carried out investigating the level of aldose reductase and glutathione in blood of the patients [8, 19]. Aldose reductase has been more frequently explored in the blood of diabetic patients [20]. Glutathione, on the other hand has been a key anti-oxidant and its value is of more significance in the ageing or senile cohort [4]. The mean GSH activity in the current study was analysed and compared among the diabetics and non-diabetics. Diabetic patients showed mean GSH activity of 3.38 μMol/g of lens which was far less than the non-diabetic group with mean of 7.48 μMol/g of lens. (Table 2). These data were substantially significant statistically with p value of < 0.001. Hence, lower levels of anti-oxidants further aggravate the oxidative stress in the lens.
The American Diabetes Association recommended glycated haemoglobin (HbA1c) as the measure of glycaemic control for the last 6–8 weeks of a patient [21]. This can also serve as an alternative to diagnosis made by the fasting blood glucose levels. HbA1c of 6.5% has been recommended as a cut-off value to diagnose diabetes [22]. In this study, the glycated haemoglobin was taken as a marker of glycaemic control in the two groups. The diabetic group showed an elevated mean HbA1c levels of 7.34% as compared to the non-diabetic group with mean HbA1c value of 5.7% (Table 2). These results were consistent with the results previous large cohort of the Beaver Dam Eye Study which stated higher HbA1c levels were strongly associated with significant risk of cortical and nuclear cataracts [6]. Similar results have been reflected in this study also. We also recorded the values of random blood sugar in each patient. The mean random blood sugar (RBS) value in the diabetic group was 151 mg/dl compared to the non-diabetic group of 101 mg/dl with p value < 0.001 which was highly significant (Table 2). However, in this study we have strictly adhered to the values of HbA1c as a marker of glycaemic control and for further statistical correlations among variables. The values of AR and GSH found in this study were further correlated with the HbA1c levels among the diabetics and non-diabetics. AR activity showed a noteworthy positive correlation (correlation coefficient 0.394) with glycated haemoglobin in the diabetic group. This was significant with p value of 0.028 (Table 4). On the other hand, non-diabetic group showed a negative correlation between AR and HbA1c, though it was not significant (Table 4). GSH activity showed no significant correlation with the HbA1c in the present study. Similar results have been reflected in a study by Bhatia et al. who correlated serum levels of AR, GSH and HbA1c in senile cataract patients [8].
This study hence demonstrates that the diabetic group showed poor glycemic control and had significantly increased aldose reductase activity and low glutathione levels which may have contributed to earlier cataract formation as compared to their non-diabetic counterpart.

Conclusion

The present study helps to establish a contribution of the Aldose reductase and glutathione activity in the lens nucleus and formation of cataract. Variables compared between the diabetic and non-diabetic groups were found to have significant value. Poor glycaemic control seen in diabetes triggers increased AR activity. Increased level of AR among the diabetic group extensively contributed to the oxidative stress in the lens. This was further worsened by the low levels of protective antioxidant glutathione whose activity was substantially less in the diabetic group as on comparison to the non-diabetic group. Elevated oxidative stress can hence be attributed to high AR and low GSH activity and can lead to early cataract formation.

Declarations

Conflict of interest

The authors have no conflict of interest.

Ethical approval

The study was approved by the Institutional Ethics Committee of Kasturba Medical College, Mangalore. (IEC KMC MLR 10-19/473).
Informed consent was obtained from all individual participants included in the study.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Literatur
1.
Zurück zum Zitat Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Global Health. 9(2). Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Global Health. 9(2).
2.
Zurück zum Zitat Neale RE, Purdie JL, Hirst LW, Green AC (2003) Sun exposure as a risk factor for nuclear cataract. Epidemiology 14(6):707CrossRefPubMed Neale RE, Purdie JL, Hirst LW, Green AC (2003) Sun exposure as a risk factor for nuclear cataract. Epidemiology 14(6):707CrossRefPubMed
3.
Zurück zum Zitat Gupta VB, Rajagopala M, Ravishankar B (2014) Etiopathogenesis of cataract: an appraisal. Indian J Ophthalmol [Internet] 62(2):103–110CrossRefPubMed Gupta VB, Rajagopala M, Ravishankar B (2014) Etiopathogenesis of cataract: an appraisal. Indian J Ophthalmol [Internet] 62(2):103–110CrossRefPubMed
4.
Zurück zum Zitat Giblin FJ (2000) Glutathione: a vital lens antioxidant. J Ocular Pharmacol Ther 16(2):121CrossRef Giblin FJ (2000) Glutathione: a vital lens antioxidant. J Ocular Pharmacol Ther 16(2):121CrossRef
5.
Zurück zum Zitat Michael R, Bron AJ (2011) The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond Ser B Biol Sci [Internet] 366(1568):1278–1292CrossRef Michael R, Bron AJ (2011) The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond Ser B Biol Sci [Internet] 366(1568):1278–1292CrossRef
6.
Zurück zum Zitat Klein BEK, Klein R, Wang Q, Moss SE (1995) Older-onset diabetes and lens opacities. The Beaver Dam Eye study. Ophthalmic Epidemiol 2(1):49CrossRefPubMed Klein BEK, Klein R, Wang Q, Moss SE (1995) Older-onset diabetes and lens opacities. The Beaver Dam Eye study. Ophthalmic Epidemiol 2(1):49CrossRefPubMed
7.
Zurück zum Zitat Kiziltoprak H, Tekin K, Inanc M, Goker YS (2019) Cataract in diabetes mellitus. World J Diabetes [Internet] 10(3):140–153CrossRefPubMed Kiziltoprak H, Tekin K, Inanc M, Goker YS (2019) Cataract in diabetes mellitus. World J Diabetes [Internet] 10(3):140–153CrossRefPubMed
8.
Zurück zum Zitat Bhatia G, Abhang S, Sontakke A (2017) Significance of aldose reductase in diabetic cataract. Int J Cur Res Rev 9:48 Bhatia G, Abhang S, Sontakke A (2017) Significance of aldose reductase in diabetic cataract. Int J Cur Res Rev 9:48
9.
Zurück zum Zitat Kinoshita JH (1981) Aldose reductase in diabetic cataracts. JAMA J Am Med Assoc 246(3):257CrossRef Kinoshita JH (1981) Aldose reductase in diabetic cataracts. JAMA J Am Med Assoc 246(3):257CrossRef
10.
Zurück zum Zitat Hayman S, Kinoshita JH (1965) Isolation and properties of lens aldose reductase. J Biol Chem 240:877–882CrossRefPubMed Hayman S, Kinoshita JH (1965) Isolation and properties of lens aldose reductase. J Biol Chem 240:877–882CrossRefPubMed
11.
Zurück zum Zitat Kisic B, Miric D, Zoric L, Ilic A, Dragojevic I (2012) Antioxidant capacity of lenses with age-related cataract. Oxid Med Cell Longev 2012:467130CrossRefPubMedPubMedCentral Kisic B, Miric D, Zoric L, Ilic A, Dragojevic I (2012) Antioxidant capacity of lenses with age-related cataract. Oxid Med Cell Longev 2012:467130CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA et al (1980) The Framingham eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24(Suppl):335PubMed Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA et al (1980) The Framingham eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24(Suppl):335PubMed
13.
Zurück zum Zitat Klein BEK, Klein R, Moss SE (1985) Prevalence of cataracts in a population- based study of persons with diabetes mellitus. Ophthalmology 92(9):1191–1196CrossRefPubMed Klein BEK, Klein R, Moss SE (1985) Prevalence of cataracts in a population- based study of persons with diabetes mellitus. Ophthalmology 92(9):1191–1196CrossRefPubMed
14.
Zurück zum Zitat Zetterberg M, Celojevic D (2015) Gender and cataract–the role of estrogen. Curr Eye Res 40(2):176CrossRefPubMed Zetterberg M, Celojevic D (2015) Gender and cataract–the role of estrogen. Curr Eye Res 40(2):176CrossRefPubMed
15.
Zurück zum Zitat Rowe NG, Mitchell PG, Cumming RG, Wans JJ (2000) Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7(2):103CrossRefPubMed Rowe NG, Mitchell PG, Cumming RG, Wans JJ (2000) Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7(2):103CrossRefPubMed
16.
Zurück zum Zitat Pollreisz A, Schmidt-Erfurth U (2010) Diabetic cataract—pathogenesis, epidemiology and treatment. J Ophthalmol. 2010. Pollreisz A, Schmidt-Erfurth U (2010) Diabetic cataract—pathogenesis, epidemiology and treatment. J Ophthalmol. 2010.
17.
Zurück zum Zitat Srivastava SK, Ramana KV, Bhatnagar A (2005) Role of aldose reductase and oxidative damage in diabetes and consequent potential for therapeutic options. Endocr Rev 26(3):380CrossRefPubMed Srivastava SK, Ramana KV, Bhatnagar A (2005) Role of aldose reductase and oxidative damage in diabetes and consequent potential for therapeutic options. Endocr Rev 26(3):380CrossRefPubMed
18.
Zurück zum Zitat Kador PF, Wyman M, Oates PJ (2016) Aldose reductase, ocular diabetic complications and the development of topical Kinostat®. Progress Retin Eye Res 54:1–29CrossRef Kador PF, Wyman M, Oates PJ (2016) Aldose reductase, ocular diabetic complications and the development of topical Kinostat®. Progress Retin Eye Res 54:1–29CrossRef
19.
Zurück zum Zitat Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T et al (2006) Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Opthalmol Vis Sci 47(5):2061–2064CrossRef Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T et al (2006) Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Opthalmol Vis Sci 47(5):2061–2064CrossRef
20.
Zurück zum Zitat Snow A, Shieh B, Chang K-C, Pal A, Lenhart P, Ammar D et al (2015) Aldose reductase expression as a risk factor for cataract. Chemico-Biol Interact 234:247CrossRef Snow A, Shieh B, Chang K-C, Pal A, Lenhart P, Ammar D et al (2015) Aldose reductase expression as a risk factor for cataract. Chemico-Biol Interact 234:247CrossRef
21.
Zurück zum Zitat Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights 11:BMI-S38440CrossRef Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights 11:BMI-S38440CrossRef
22.
Zurück zum Zitat Gillett MJ (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327CrossRef Gillett MJ (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327CrossRef
Metadaten
Titel
Aldose reductase and glutathione in senile cataract nucleus of diabetics and non-diabetics
verfasst von
Kanishk Khare
Teena Mendonca
Gladys Rodrigues
Manjunath Kamath
Anupama Hegde
Shyamala Nayak
Ajay Kamath
Sumana Kamath
Publikationsdatum
03.07.2023
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 10/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-023-02776-1

Weitere Artikel der Ausgabe 10/2023

International Ophthalmology 10/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.